Xtrackers MSCI World UCITS ETF 1D GBP is a equity ETF from Xtrackers tracking the MSCI World index through physical replication. Domiciled in Ireland and launched in 2015, the fund manages about 4.7 bn € and charges a TER of 0.12% — 12 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Xtrackers MSCI World UCITS ETF 1D GBP competes with 26 other products on the same index (MSCI World): it ranks 15th by fund size and 4th by ongoing cost, with a TER of 0.12% against a group median of 0.20%. It has been listed since 2015, 11 years of track record.
On a €10,000 investment the TER costs 12 € a year. The cheapest of the group is Invesco MSCI World UCITS ETF EUR at 0.05%, or 5 € on the same amount: a difference of 7 € every year, roughly 70 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 25.7% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in GBP. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 5.2% |
| Apple Inc. | 4.8% |
| Microsoft Corporation | 2.9% |
| Amazon.com Inc | 2.6% |
| Alphabet Inc Class A | 2.3% |
| Broadcom Inc | 1.9% |
| Alphabet Inc Class C | 1.8% |
| Micron Technology Inc | 1.5% |
| Meta Platforms Inc. | 1.4% |
| Tesla Inc | 1.3% |
| XETRA | XDWL | EUR |
| Francoforte | XDWL | EUR |
| London Stock Exchange | XDWP | GBP |
| London Stock Exchange | XDWL | USD |
| SIX Swiss Exchange | XDWL | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.